Executive Profile

J. Melville (“Mel”) Engle, Chairman and CEO of Predictive Oncology

Executive Profile

J. Melville (“Mel”) Engle, Chairman and CEO of Predictive Oncology

Mel Engle has over 20 years’ successful leadership experience in both the biotechnology and healthcare industries. During his career he was elevated to multiple top-level positions as President, CEO, Director, Chairman of the Board, CFO, Regional Director (North America), Managing Director (Canada) and Senior VP of Sales (US) in both public and private companies. Mel has a well-earned reputation for driving sales and has launched hundreds of products while guiding companies to profitability. Mel joined POAI’s Board of Directors in October 2016, was appointed Chairman of the Board in January 2020 and CEO in March 2021. He now serves as both the Chairman and CEO of Predictive Oncology, a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery.

Prior to starting a specialized CEO consulting practice in 2012, Mr. Engle was CEO and Chairman of the Board of Thermogenesis, a NASDAQ listed company which designed, developed, and sold medical devices that enabled the practice of regenerative medicine. He previously served as Lead Independent Director of the Board of NASDAQ listed Oxygen Biotherapeutics which invented and developed a proprietary perfluorocarbon therapeutic oxygen carrier to efficiently deliver oxygen to body tissues. Mel was recruited by Merck KGaA in 2002 to serve as President and CEO of Dey L.P, a division of Merck, where he was instrumental in increasing sales from $250 million to over $600 million during his tenure. During his 14 years with Allergan Inc., Mel rose to senior executive positions and played key roles in the organization as CFO, Managing Director, Canada (located in Toronto), Senior Vice President, Latin America/Canada, and Senior Vice President, U.S. Sales.

CEO and Board tested, Mel has demonstrated proficiency in R&D, M&A, new product development and market growth initiatives. Mel holds a BS in Accounting from the University of Colorado (Boulder), and an MBA in Finance from University of Southern California (Los Angeles).

Additional Resources
J. Melville (“Mel”) Engle, Chairman and CEO of Predictive OncologyCompany News & Information
News & Media Overview Chart Financials Filings Time & Sales Historical Data

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717

View All Solutions

You’re already more familiar with brand awareness than you might think. What’s your favorite brand of soft drink, athletic shoe, car, shampoo, streaming content provider? Chances are, you first tried those brands because of their awareness strategies. Whether it was word of mouth or a TV commercial, Facebook post, billboard or coupon, that awareness peaked interest, triggered a purchase reaction, and ideally built customer loyalty.

More About Brand Awareness

5,000+ key syndication outlets across the country. IBN’s extensive system of strategic distribution points maximizes your exposure to an audience of millions, including journalists, investors, day traders, fund managers and a multitude of other interested individuals. Now your press releases, earnings statements, branded articles, shareholder updates, corporate achievements can reach a vast and diverse nationwide audience.

More About InvestorWire

Make sure your message resonates. IBN integrates social media with traditional distribution channels to make sure your message resonates long after initial publication. This innovative model ensures that your news not only crosses the wire, but keeps reverberating via social conversation on Twitter, Facebook, LinkedIn and other social networks.

More About Social MediaIBN Social Media NetworkSocial Media Statistics & FAQs

A unique format with a traditionally different sensory input – hearing.As conferences and events continue to suffer cancellations and greatly reduced attendance, many businesses are wondering how to network with large investor audiences in the new normal. At the same time podcasts have seen a jump in popularity.

More About IBN Podcast Solutions